Runx3 is required for full activation of regulatory T cells to prevent colitis-associated tumor formation

Manabu Sugai1, Koji Aoki, Motomi Osato

  • 1Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, Sakyo-ku, Kyoto 606-8507, Japan.

Related Concept Videos